Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Liaoyuan Pharmaceutical is a prominent Chinese manufacturer specializing in active pharmaceutical ingredients (APIs) and fine chemical intermediates. Established in 1993, the company has developed a robust infrastructure for the large-scale synthesis of complex organic molecules, particularly for cardiovascular and antiviral applications. Their facilities are designed to meet international regulatory standards, including GMP certifications, enabling them to export products to markets in Europe, North America, and Asia. The company provides both catalog products and custom synthesis services to the global pharmaceutical industry. With a focus on technical innovation and quality control, Zhejiang Liaoyuan has become a critical link in the supply chain for several essential generic and branded medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Liaoyuan.